Answers are grounded in this paper and cite their sources.
The recent Field Corrective Action (FCA) for the HiRes Ultra and Ultra 3D (V1) cochlear implants (CIs) triggered much research investigating clinical identification, failure rates, and postrevision outcomes. Pediatric data remain limited, especially with regards to speech outcomes. We aim to characterize the trajectory of children implanted with these devices with specific attention to speech outcomes.
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: